BGMS — Bio Green Med Solution, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on BGMS
| date | signal | measured base rate |
|---|---|---|
| 2026-07-29 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-06-10 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-04-20 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-11-12 | Doris Wong Sing Ee Chief Executive Officer | Grant or award | 300.2K | 1.40 | 420.2K |
| 2025-11-12 | Kiu Cu Seng Chief Financial Officer | Grant or award | 200.0K | 1.40 | 280.0K |
| 2025-11-05 | Yap Kim Choy | Open-market sale | 28.5K | 1.70 | 48.5K |
| 2025-11-05 | Yap Kim Choy | Other Acquisition/Disposition | 467.5K | 0.00 | 0 |
| 2025-11-05 | Ong Yee Lung | Other Acquisition/Disposition | 467.5K | 0.00 | 0 |
| 2025-11-05 | Kua Khai Loon | Other Acquisition/Disposition | 467.5K | 0.00 | 0 |
| 2025-10-30 | Ong Yee Lung | Open-market sale | 248.8K | 1.80 | 447.9K |
| 2025-10-30 | Kua Khai Loon | Open-market sale | 242.5K | 1.80 | 436.5K |
| 2025-10-30 | Yap Kim Choy | Open-market sale | 112.3K | 1.81 | 203.2K |
| 2025-10-29 | Yap Kim Choy | Open-market sale | 110.7K | 1.83 | 202.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 46.1K | 46.1K |
| CITADEL ADVISORS LLC | 22.1K | 22.1K |
| XTX Topco Ltd | 21.9K | 21.9K |
| GEODE CAPITAL MANAGEMENT, LLC | 21.6K | 21.6K |
| Tower Research Capital LLC (TRC) | 4.3K | 4.3K |
| UBS Group AG | 2.2K | 2.2K |
| SBI Securities Co., Ltd. | 500 | 500 |
| Archer Investment Corp | 1 | 1 |
| OSAIC HOLDINGS, INC. | 1 | 1 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-12 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-12 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-12 | — | on EDGAR ↗ |
| S-4/A | 2026-07-24 | — | on EDGAR ↗ |
| 8-K | 2026-07-01 | 2026-07-01 | on EDGAR ↗ |
| 8-K | 2026-06-22 | 2026-06-18 | on EDGAR ↗ |
| S-4 | 2026-06-16 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Bio Green Med Solution, Inc. (BGMS) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Bio Green Med Solution, Inc. (BGMS) filed form 8-K · 2026-08-14 · SEC EDGAR
- Bio Green Med Solution, Inc. (BGMS) filed form SCHEDULE 13G/A · 2026-08-12 · SEC EDGAR
- Bio Green Med Solution, Inc. (BGMS) filed form SCHEDULE 13G/A · 2026-08-12 · SEC EDGAR
Ask the AI about BGMS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →